Arthur O. Frankel,Melvin Lathara,Celine Y. Shaw,Owen Wogmon,Jacob M. Jackson,Mattie M. Clark,Navah Eshraghi,Stephanie E. Keenen,Andrew D. Woods,Reshma Purohit,Yukitomo Ishi,Nirupama Moran,Mariko Eguchi,Farhat Ul Ain Ahmed,Sara Khan,Maria Ioannou,Konstantinos Perivoliotis,Pin Li,Huixia Zhou,Ahmad Alkhaledi,Elizabeth J. Davis,Danielle Galipeau,Agnieszka Wozniak,Patrick Schoffski,Paul H. Huang,Robin L. Jones,Brian P. Rubin,Morgan Darrow,Ganapati Srinivasa,Erin R. Rudzinski,Sonja Chen,Noah E. Berlow,Charles Keller,R. Lor Randall,Jerry Lee

Abstract:Correctly diagnosing a rare childhood cancer such as sarcoma can be critical to assigning the correct treatment regimen. With a finite number of pathologists worldwide specializing in pediatric/young adult sarcoma histopathology, access to expert differential diagnosis early in case assessment is limited for many global regions. The lack of highly-trained sarcoma pathologists is especially pronounced in low to middle-income countries, where pathology expertise may be limited despite a similar rate of sarcoma incidence. To address this issue in part, we developed a deep learning convolutional neural network (CNN)-based differential diagnosis system to act as a pre-pathologist screening tool that quantifies diagnosis likelihood amongst trained soft-tissue sarcoma subtypes based on whole histopathology tissue slides. The CNN model is trained on a cohort of 424 centrally-reviewed histopathology tissue slides of alveolar rhabdomyosarcoma, embryonal rhabdomyosarcoma and clear-cell sarcoma tumors, all initially diagnosed at the originating institution and subsequently validated by central review. This CNN model was able to accurately classify the withheld testing cohort with resulting receiver operating characteristic (ROC) area under curve (AUC) values above 0.889 for all tested sarcoma subtypes. We subsequently used the CNN model to classify an externally-sourced cohort of human alveolar and embryonal rhabdomyosarcoma samples and a cohort of 318 histopathology tissue sections from genetically engineered mouse models of rhabdomyosarcoma. Finally, we investigated the overall robustness of the trained CNN model with respect to histopathological variations such as anaplasia, and classification outcomes on histopathology slides from untrained disease models. Overall positive results from our validation studies coupled with the limited worldwide availability of sarcoma pathology expertise suggests the potential of machine learning to assist local pathologists in quickly narrowing the differential diagnosis of sarcoma subtype in children, adolescents, and young adults.

Classifying Sarcoma Cancer Using Deep Neural Networks Based on Multi-Omics Data

A Novel Hybrid Approach for Classifying Osteosarcoma Using Deep Feature Extraction and Multilayer Perceptron

Advanced Hybrid Deep Learning Model for Enhanced Classification of Osteosarcoma Histopathology Images

Classifying Breast Cancer Subtypes Using Deep Neural Networks Based on Multi-Omics Data

A deep learning study on osteosarcoma detection from histological images

From Human Mesenchymal Stromal Cells to Osteosarcoma Cells Classification by Deep Learning

Comparative Analysis of Multi-Omics Integration Using Advanced Graph Neural Networks for Cancer Classification

A novel deep learning framework for accurate melanoma diagnosis integrating imaging and genomic data for improved patient outcomes

Multi-class Skin Cancer Classification Architecture Based on Deep Convolutional Neural Network

Multimodal Non-Small Cell Lung Cancer Classification Using Convolutional Neural Networks

Application of the convolutional neural networks and supervised deep-learning methods for osteosarcoma bone cancer detection

Optimizing and Visualizing Deep Learning for Benign/Malignant Classification in Breast Tumors

Automating cancer diagnosis using advanced deep learning techniques for multi-cancer image classification

Multi-modal classification for human breast cancer prognosis prediction: Proposal of deep-learning based stacked ensemble model

Machine learning for rhabdomyosarcoma histopathology

Diagnosis of Oral Squamous Cell Carcinoma Using Deep Neural Networks and Binary Particle Swarm Optimization on Histopathological Images: An AIoMT Approach

Skin cancer classification dermatologist-level based on deep learning model

BCCHI-HCNN: Breast Cancer Classification from Histopathological Images Using Hybrid Deep CNN Models

A hybrid deep CNN model for brain tumor image multi-classification

DeepSurvNet: deep survival convolutional network for brain cancer survival rate classification based on histopathological images

Deep learning-driven multi-omics sequential diagnosis with Hybrid-OmniSeq: Unraveling breast cancer complexity